radioiodine
radioiodine is a radiation therapy with 7 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
5 of 5 finished
0.0%
0 ended early
2
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Follow up for Patients With Thyroid Cancer Planed for Radioiodine Scan or Treatment
Treatment Efficacy and Safety of Low-dose Radioiodine Ablation for Intermediate-risk Differentiated Thyroid Carcinoma
Salivary dysfuncTion After Radioiodine Treatment
Effect of Childhood Radioiodine Therapy on Salivary Function
Low-dose Radioiodine Ablation in Graves' Disease
Clinical Trials (7)
Follow up for Patients With Thyroid Cancer Planed for Radioiodine Scan or Treatment
Treatment Efficacy and Safety of Low-dose Radioiodine Ablation for Intermediate-risk Differentiated Thyroid Carcinoma
Salivary dysfuncTion After Radioiodine Treatment
Effect of Childhood Radioiodine Therapy on Salivary Function
Low-dose Radioiodine Ablation in Graves' Disease
Comparison of Different Doses of 131I in Severe Graves' Hyperthyroidism
Dental Safety Profile of High-Dose Radioiodine Therapy
All 7 trials loaded
Drug Details
- Intervention Type
- RADIATION
- Total Trials
- 7